| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $857.2M | +7.6% |
| Cost of Revenue | $279.4M | +25.8% |
| Gross Profit | $577.8M | +0.6% |
| R&D Expense | $96.0M | +4.4% |
| SG&A Expense | $137.1M | +0.3% |
| Operating Income | $40.2M | +67.9% |
| Pre-tax Income | $66.8M | +38.3% |
| Income Tax | $43.9M | +159.9% |
| Net Income | $22.9M | -81.2% |
| EPS (Basic) | $0.09 | -80.9% |
| EPS (Diluted) | $0.09 | -79.5% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $163.0M | +12.2% |
| Current Assets | $888.0M | +4.0% |
| Total Assets | $1.21B | +1.8% |
| Current Liabilities | $554.1M | +7.1% |
| Total Liabilities | $612.4M | +7.0% |
| Stockholders' Equity | $592.6M | -3.2% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $159.2M | +105.2% |
| Capital Expenditures | $1.4M | -76.2% |
| Investing Cash Flow | -$12.5M | -108.1% |
| Financing Cash Flow | -$131.8M | +46.9% |
| Free Cash Flow | $157.8M | +119.8% |